Thyroid-Stimulating Hormone (TSH) Testing: Principles, Methods, Standards, and Clinical Applications

Thyroid-stimulating hormone (TSH) testing quantifies the concentration of thyrotropin in human serum or plasma and is the first-line laboratory assay for evaluating thyroid function. Because TSH reflects the sensitive negative-feedback balance of the hypothalamic–pituitary–thyroid axis, this high-sensitivity immunoassay is indispensable for diagnosing hypothyroidism, hyperthyroidism, and subclinical thyroid dysfunction, as well as for monitoring hormone replacement and antithyroid therapy. This article provides a comprehensive technical review of TSH testing principles, sample requirements, analytical methods, quality standards, and clinical applications.

Technical Overview

Thyroid-stimulating hormone (TSH), also known as thyrotropin, is a glycoprotein hormone of approximately 28 kDa synthesized and secreted by the thyrotropic cells of the anterior pituitary gland. It consists of two non-covalently linked subunits: an alpha subunit shared with luteinizing hormone, follicle-stimulating hormone, and human chorionic gonadotropin, and a hormone-specific beta subunit that confers its unique biological activity. TSH binds to the TSH receptor on thyroid follicular cells, stimulating iodide uptake, thyroglobulin synthesis, and the production and secretion of thyroxine (T4) and triiodothyronine (T3).

TSH secretion is governed by the hypothalamic–pituitary–thyroid (HPT) axis. Elevated circulating free T4 and free T3 suppress pituitary TSH release, whereas declining thyroid hormone levels trigger a logarithmic rise in TSH output. Because of this inverse logarithmic relationship, serum TSH is the single most sensitive indicator of thyroid hormone status in patients with an intact pituitary gland: early primary thyroid dysfunction almost always produces an abnormal TSH value before free hormone concentrations leave their reference intervals.

Contemporary TSH assays are third-generation, noncompetitive immunometric (sandwich) methods with a functional sensitivity of approximately 0.01–0.02 mIU/L, allowing reliable discrimination between low-normal and truly suppressed concentrations. Results are reported in mIU/L, and calibrations on major platforms are traceable to the WHO 2nd International Standard for TSH (80/558) in accordance with the metrological traceability framework of ISO 17511. Typical adult reference intervals range from roughly 0.4 to 4.5 mIU/L, although exact limits vary by analytical system, population, and age, and trimester-specific intervals apply during pregnancy.

Testing Samples

Serum (Primary Matrix)

A venous blood specimen of 2–5 mL is collected into a plain tube or a serum-separator tube and allowed to clot completely, typically for 30 minutes at room temperature, before centrifugation. Serum is the reference matrix for TSH measurement on virtually all automated immunoassay platforms. After separation, TSH is stable for approximately 5–7 days at 2–8 °C and for several months at −20 °C or colder; repeated freeze–thaw cycles should be avoided. Standard precautions regarding patient identification and tube labeling are mandatory, and testing should comply with the quality management requirements of ISO 15189.

Plasma

Lithium-heparin and EDTA plasma are acceptable alternatives on many analytical systems, provided the manufacturer's validated specimen claims are confirmed by the laboratory. Plasma TSH concentrations are generally comparable to serum values, but matrix types should not be interchanged when serially monitoring an individual patient. Marked hemolysis, icterus, or lipemia may interfere with optical or electrochemical detection and should be documented, with recollection requested when sample integrity is compromised.

Dried Blood Spots

For large-scale neonatal congenital hypothyroidism screening, capillary heel-prick blood is applied to standardized filter-paper cards, dried thoroughly at ambient temperature, and shipped to a centralized screening laboratory. Discs punched from the dried spot are eluted and analyzed by highly sensitive time-resolved fluoroimmunoassay or chemiluminescent protocols. Dried blood spots offer excellent logistical simplicity and multi-week stability, making them ideal for population-based newborn screening programs.

Testing Items

The core deliverable is a quantitative TSH concentration in serum or plasma. In routine practice, TSH is embedded in broader thyroid panels or reflex-testing algorithms that improve diagnostic specificity:

• Ultra-sensitive (third-generation) TSH quantification with functional sensitivity of 0.01–0.02 mIU/L
• Free T4 (FT4) and free T3 (FT3) as confirmatory second-line tests when TSH falls outside the reference interval
• Thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb) for the evaluation of autoimmune thyroid disease
• TSH receptor antibodies (TRAb) for the differential diagnosis of Graves' disease
• Thyroglobulin monitoring following treatment of differentiated thyroid carcinoma
• Trimester-specific TSH and FT4 panels for prenatal, obstetric, and fertility assessment

Interpretation follows a well-defined matrix: elevated TSH with low FT4 indicates primary hypothyroidism; suppressed TSH with elevated FT4 indicates primary thyrotoxicosis; TSH abnormalities with normal FT4 define subclinical disease; and an inappropriately low or normal TSH in the presence of low FT4 suggests central (pituitary or hypothalamic) hypothyroidism.

Testing Methods

All routine TSH methods are two-site noncompetitive immunometric assays in which a solid-phase capture antibody and a labeled detection antibody bind simultaneously to distinct epitopes on the TSH molecule. The generated signal is directly proportional to the TSH concentration in the specimen. The principal platform technologies are summarized below.

Chemiluminescent Immunoassay (CLIA)

CLIA is the most widely deployed technology on modern automated analyzers, employing acridinium-ester or alkaline-phosphatase chemiluminescent substrates. It offers rapid turnaround, random-access operation, and throughput of several hundred to several thousand tests per hour, making it the backbone of hospital core laboratories and high-volume reference laboratories.

Electrochemiluminescence Immunoassay (ECLIA)

ECLIA uses ruthenium-complex-labeled antibodies and tripropylamine chemistry triggered at an electrode surface, delivering an exceptionally wide dynamic range and superior precision at the low end of the measurement interval. This performance profile is particularly valuable for evaluating suppressed TSH states such as Graves' disease and TSH-suppression therapy after thyroid cancer.

Enzyme-Linked Immunosorbent Assay (ELISA)

Microplate-based ELISA using horseradish-peroxidase and TMB colorimetric detection remains a cost-effective open-system option for small laboratories, research settings, and epidemiological studies. It demands disciplined control of incubation temperature, washing efficiency, and timing, and generally provides lower throughput and somewhat longer turnaround than automated platforms.

Immunofluorometric Assay

Time-resolved fluoroimmunoassay based on lanthanide (europium) chelate labels combines very high sensitivity with a stable, low-background signal. It is a proven methodology in neonatal dried-blood-spot screening, where detection of mildly elevated TSH in a small eluate is essential.

Radioimmunoassay (Historical Reference)

The original competitive radioimmunoassay represented the first and second TSH assay generations and established the clinical utility of TSH measurement. It has been almost entirely superseded because of limited sensitivity at low concentrations and the regulatory burden of radioisotope handling, although legacy RIA datasets remain relevant for longitudinal epidemiological comparisons.

Quality Assurance, Traceability, and Interference Control

Calibrators and control materials should be traceable to higher-order references such as the WHO International Standard, consistent with ISO 17511, and reagent manufacturing is expected to conform to ISO 13485. Clinical laboratories should operate under ISO 15189 accreditation or its national equivalent such as GB/T 22576, running at least two levels of internal quality control per analytical run with statistically justified acceptance rules and participating regularly in external quality assessment schemes. Known interferences include heterophilic antibodies and human anti-mouse antibodies, high-dose biotin in streptavidin–biotin systems, macro-TSH complexes, and the high-dose hook effect at extreme concentrations; mitigation relies on blocking reagents, serial dilution with assessment of linearity, and method comparison against an orthogonal platform when results conflict with the clinical picture.

Applications

TSH testing is among the highest-volume immunoassays in clinical laboratories worldwide, supporting diagnosis, therapy management, and public health screening:

• Diagnosis of overt and subclinical primary hypothyroidism
• Diagnosis of overt and subclinical thyrotoxicosis, including Graves' disease and toxic nodular goiter
• Initiation and lifelong titration of levothyroxine replacement therapy, with a typical monitoring target of 0.4–4.0 mIU/L or tailored low targets after thyroid cancer
• Monitoring of antithyroid drug therapy and assessment before radioiodine or surgical ablation
• Newborn screening for congenital hypothyroidism, enabling early intervention that prevents irreversible neurodevelopmental impairment
• Prenatal and fertility evaluation, including first-trimester thyroid function assessment and management of hypothyroidism in pregnancy
• Population health examinations, occupational screening programs, and large-scale epidemiological studies
• Support for endocrinology research, clinical trials, and biobank studies in accredited third-party laboratories
• Differentiation of primary from secondary (central) thyroid dysfunction when interpreted together with FT4

FAQ

Is fasting required before a TSH blood test?

Fasting is generally not required, and TSH can be drawn at any time of day for routine evaluation. However, because TSH exhibits a modest diurnal rhythm with a nocturnal peak, specimens for serial monitoring of patients on therapy are best collected at consistent times of day to minimize interpretive variability.

What does a high TSH result mean?

An elevated TSH most commonly indicates primary hypothyroidism, meaning the thyroid gland is underproducing T4 and T3 while the pituitary compensates by increasing TSH output. Causes include Hashimoto's thyroiditis, iodine deficiency, previous thyroid surgery or radioiodine therapy, and certain medications such as lithium and amiodarone. Confirmation with FT4 and antibody testing clarifies overt versus subclinical disease.

What does a low TSH result mean?

A suppressed TSH usually signals thyrotoxicosis from Graves' disease, toxic nodules, or exogenous hormone excess, but it may also reflect deliberate TSH-suppression therapy after differentiated thyroid cancer, early pregnancy due to hCG cross-stimulation, non-thyroidal illness, or central hypothyroidism when FT4 is concurrently low. Clinical correlation and follow-up FT4/FT3 testing are essential.

Can medications or supplements interfere with the assay?

Yes. High-dose biotin supplements can falsely lower TSH on streptavidin–biotin platforms, and regulatory guidance recommends withholding high-dose biotin for at least 8 hours before sampling. Dopamine, glucocorticoids, octreotide, amiodarone, lithium, and metoclopramide can genuinely alter TSH secretion, while heterophilic antibodies may cause spurious results on any immunoassay.

How quickly are results available?

On automated CLIA and ECLIA systems in accredited clinical laboratories, results are typically reported within a few hours of receipt, with urgent neonatal confirmatory testing prioritized accordingly. Manual ELISA workflows generally yield same-day or next-day results.

Why do TSH reference intervals differ between laboratories?

Intervals are method-specific because calibrator matrices, antibody specificity, and signal chemistry vary between platforms, and they are also influenced by population demographics, age, and sex. Each laboratory operating under ISO 15189 must verify or establish its own reference intervals, and separate trimester-specific intervals are applied during pregnancy, with first-trimester values commonly as low as 0.1 mIU/L at the lower limit.